United States v. Sheldon Kresler

392 F. App'x 765
CourtCourt of Appeals for the Eleventh Circuit
DecidedAugust 16, 2010
Docket08-13204
StatusUnpublished
Cited by2 cases

This text of 392 F. App'x 765 (United States v. Sheldon Kresler) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Sheldon Kresler, 392 F. App'x 765 (11th Cir. 2010).

Opinion

PER CURIAM:

This is an appeal from a judgment, entered after a jury trial, convicting the appellant, Sheldon Kresler, of one count of conspiracy in violation of 18 U.S.C. § 371, seven counts of wire fraud in violation of 18 U.S.C. § 1343, one count of prescription drug diversion in violation of 21 U.S.C. §§ 331 (t), 333(a)(2), 353(c)(3)(A)(i) and 353(c)(3)(A)(ii)(II), one count of money laundering conspiracy in violation of 18 U.S.C. § 1956(h), and nine counts of money laundering in violation of 18 U.S.C. § 1956(a)(l)(B)(i). Kresler, who had an extensive criminal history, was sentenced principally to ninety-six months of incarceration. On this appeal, he challenges both his conviction and sentence.

BACKGROUND

I. The Scheme to Defraud

Kresler and co-defendant William Walker were co-owners of Crystal Coast Inc. (“Crystal Coast”), a pharmaceutical resale company based in Miami, Florida. Kres-ler and Walker established Crystal Coast in order to purchase pharmaceuticals from various sources and resell the drugs to wholesalers at a profit. In November 1999, Leonard Schecter, an acquaintance of Kresler’s, introduced Kresler and Walker to Mark Linden, another co-defendant, who was the owner of Marisa Trading. Linden informed Kresler and Walker that he could secure quantities of InFed, a branded generic drug used to treat iron deficiency and anemia produced by Schein Pharmaceuticals Inc. (“Schein”), at a low price through Charles Williams, also a co-defendant. Williams, who was the executive director of African Christian Relief (“ACR”), a 501(c)(3) charitable organization, had contacted a representative of Schein’s humanitarian aid division to procure InFed for distribution to Angola, Africa. Williams had submitted materials to Schein, including documentation substantiating that ACR was a registered 501(c)(3) organization and ACR’s annual report. Schein agreed to provide InFed at the rate of $88.00 per unit, a deep discount from its normal price.

Williams never intended to ship the In-Fed acquired from Schein to Angola. Instead, he planned to sell the drugs on the domestic market for a hefty profit. Kres-ler and Walker, through Crystal Coast, agreed with Williams and Linden to sell *768 the InFed obtained from Schein to wholesalers at a significant markup from their purchase price. Crystal Coast, however, did not have a pharmaceutical wholesalers license. Consequently, Crystal Coast arranged to use the license held by James P. Lyons & Son, a company based out of Fort Lauderdale, Florida. At trial, Walker testified that he knew this arrangement was illegal.

Kresler, Walker, Williams and Linden retained an attorney, Louis Terminello, of Terminello & Terminello, to act as an escrow agent. In essence, Crystal Coast would sell InFed to wholesalers, who would remit a portion of the purchase price to the escrow account held by Termi-nello. Terminello would then distribute a portion of these proceeds to Schein for the purchase of the pre-sold InFed. Once the payment was received by Schein, it would ship the purchased InFed to freight forwarder Vene-Embarque, Inc. (“Vene-Embarque”), which was located in Miami. Kresler or Walker (or both) would physically pick up the InFed from Vene-Emb-arque, repackage the drugs, and in some cases personally deliver it to the wholesalers. Once delivery was completed, the wholesalers would remit the remainder of the purchase price to Crystal Coast or Terminello. Terminello would then distribute the remaining profits to the co-conspirators, after deducting fees for himself, Schecter, and James P. Lyons & Son.

Between November 1999 and January 2000, Williams ordered eight shipments of InFed from Schein, totaling 22,718 units at a total cost of $1,999,184.00. Of the eight shipments, seven were processed as contemplated. Prior to the final shipment, Schein discovered that Crystal Coast had been reselling drugs obtained from ACR, and cancelled the last order. In all, Crystal Coast sold the seven successfully-received shipments to wholesalers for $3,058,690.00. Over the three months that the scheme was operational, Kresler and Walker each earned a total of approximately $500,000 from these transactions.

II. Kresler’s Flight to Israel

Because the principal issue raised on this appeal relates to Kresler’s claim that he was deprived of his right to a speedy trial, we set out a detailed narrative of the undisputed facts relating to the cause of the delay. On October 1, 2003, Kresler was interviewed by Special Agent Mallon of the Food and Drug Administration at a Denny’s Restaurant in Miami. At that interview, Kresler indicated his willingness to cooperate with the investigation regarding ACR and Williams. On February 6, 2004, during a telephone conversation, Kresler told Agent Mallon that he was in Israel and that he would return to the United States at some point in the next month. Kresler agreed to contact Mallon when he returned to the United States. On March 2, 2004, Mallon again contacted Kresler by telephone. This time, Kresler indicated that he had broken his leg in Israel and would not return to the United States for another six to eight weeks.

The grand jury returned an indictment against Kresler on April 8, 2004. On June 23, 2004, presumably in response to a request for assistance by the United States, INTERPOL provided Kresler’s street address in Israel to the United States Attorney and advised that Kresler’s name was in the border control lookout list. INTERPOL also provided a request for consideration of arrest and extradition, and this request was sent to the International Department at the Israeli Ministry of Justice for further evaluation. By then,' Kres-ler had become an Israeli citizen. The request for extradition apparently was not pressed because the United States Attorney was under the mistaken belief that *769 Israel would not extradite one of its citizens. Since 1999, however, Israeli law permitted extradition for its citizens for some offenses (including fraud) provided that the sentence imposed was served in Israel.

Nevertheless, INTERPOL continued to track Kresler’s movements. On September 2, 2005, INTERPOL provided information that Kresler had reserved airline tickets from Tel Aviv to Geneva under the name of “Ariel Kersler” for a flight on August 28, 2005. Subsequently, on September 11, 2005, Kresler sent an email to Walker’s wife boasting that he “[had] a way for all the charges to be dropped against [Walker], but it will cost money!” Ten days later, on September 21, 2005, Kresler sent another email to Walker’s wife asking, “Do you want Billey boy to stay in jail?” Kresler attached a printout of the docket sheet in this case, which indicated that Kresler was one of the defendants.

Kresler continued to travel to and from Israel. On December 19, 2005, INTERPOL obtained information that Kresler had re-entered Israel three days prior.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Demirtas
District of Columbia, 2016

Cite This Page — Counsel Stack

Bluebook (online)
392 F. App'x 765, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-sheldon-kresler-ca11-2010.